James Michael Richter, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colonoscopy | 13 | 2022 | 1367 | 2.450 |
Why?
|
Colitis, Ulcerative | 28 | 2023 | 1912 | 1.930 |
Why?
|
Crohn Disease | 22 | 2023 | 2303 | 1.440 |
Why?
|
Colorectal Neoplasms | 12 | 2022 | 6773 | 1.220 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2016 | 868 | 0.960 |
Why?
|
Cathartics | 2 | 2022 | 125 | 0.920 |
Why?
|
Gastrointestinal Hemorrhage | 4 | 2022 | 1130 | 0.920 |
Why?
|
Colitis, Microscopic | 5 | 2022 | 77 | 0.860 |
Why?
|
Guideline Adherence | 3 | 2019 | 2266 | 0.850 |
Why?
|
Early Detection of Cancer | 11 | 2022 | 3086 | 0.850 |
Why?
|
Adenoma | 5 | 2021 | 2174 | 0.770 |
Why?
|
Adenomatous Polyps | 1 | 2019 | 107 | 0.650 |
Why?
|
Inflammatory Bowel Diseases | 9 | 2023 | 2425 | 0.590 |
Why?
|
Colonic Polyps | 2 | 2019 | 542 | 0.570 |
Why?
|
Hepatic Encephalopathy | 1 | 2017 | 139 | 0.560 |
Why?
|
Proctocolitis | 1 | 2016 | 25 | 0.550 |
Why?
|
Mesalamine | 1 | 2016 | 136 | 0.520 |
Why?
|
Telenursing | 1 | 2014 | 2 | 0.520 |
Why?
|
Adenocarcinoma | 3 | 2019 | 6364 | 0.510 |
Why?
|
Liver Cirrhosis | 4 | 2021 | 1863 | 0.500 |
Why?
|
Quality Indicators, Health Care | 4 | 2019 | 1831 | 0.500 |
Why?
|
Nurse Anesthetists | 1 | 2014 | 18 | 0.490 |
Why?
|
Cecal Neoplasms | 1 | 2014 | 29 | 0.490 |
Why?
|
Helicobacter pylori | 2 | 2017 | 382 | 0.480 |
Why?
|
Digestive System Diseases | 1 | 2016 | 147 | 0.480 |
Why?
|
Helicobacter Infections | 2 | 2017 | 386 | 0.480 |
Why?
|
International Normalized Ratio | 1 | 2015 | 367 | 0.470 |
Why?
|
Outpatients | 2 | 2019 | 1486 | 0.470 |
Why?
|
Deep Sedation | 1 | 2014 | 121 | 0.440 |
Why?
|
Endoscopy, Digestive System | 1 | 2015 | 345 | 0.430 |
Why?
|
Gastroenterology | 2 | 2018 | 536 | 0.430 |
Why?
|
Heart-Assist Devices | 1 | 2022 | 1194 | 0.420 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2282 | 0.410 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 504 | 0.400 |
Why?
|
Telephone | 1 | 2014 | 617 | 0.390 |
Why?
|
Microsatellite Instability | 1 | 2014 | 684 | 0.370 |
Why?
|
Endosonography | 1 | 2014 | 610 | 0.370 |
Why?
|
Inpatients | 2 | 2022 | 2518 | 0.360 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1170 | 0.350 |
Why?
|
Continuity of Patient Care | 2 | 2020 | 1049 | 0.320 |
Why?
|
Colonic Neoplasms | 3 | 2020 | 2541 | 0.320 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2208 | 0.310 |
Why?
|
Conscious Sedation | 1 | 2012 | 528 | 0.310 |
Why?
|
Celiac Disease | 3 | 2021 | 785 | 0.300 |
Why?
|
Patient Readmission | 2 | 2020 | 3114 | 0.300 |
Why?
|
Warfarin | 1 | 2015 | 1496 | 0.300 |
Why?
|
Electronic Health Records | 3 | 2015 | 4468 | 0.290 |
Why?
|
Acute Disease | 1 | 2017 | 7149 | 0.280 |
Why?
|
Prospective Studies | 36 | 2023 | 53288 | 0.280 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2014 | 941 | 0.280 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 1162 | 0.280 |
Why?
|
Diffusion of Innovation | 1 | 2011 | 725 | 0.280 |
Why?
|
Insurance Coverage | 1 | 2017 | 1901 | 0.270 |
Why?
|
Quality Improvement | 3 | 2020 | 3749 | 0.270 |
Why?
|
Incidence | 22 | 2023 | 20947 | 0.270 |
Why?
|
Humans | 81 | 2024 | 744343 | 0.260 |
Why?
|
Risk Factors | 32 | 2023 | 72290 | 0.250 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7279 | 0.240 |
Why?
|
Middle Aged | 44 | 2022 | 213383 | 0.240 |
Why?
|
Mass Screening | 4 | 2021 | 5255 | 0.240 |
Why?
|
Length of Stay | 1 | 2017 | 6309 | 0.240 |
Why?
|
Telemedicine | 1 | 2021 | 2872 | 0.230 |
Why?
|
Aged | 28 | 2022 | 163280 | 0.230 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2916 | 0.230 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2020 | 379 | 0.220 |
Why?
|
Female | 52 | 2023 | 380194 | 0.220 |
Why?
|
Contraceptives, Oral | 2 | 2018 | 564 | 0.220 |
Why?
|
Decision Support Systems, Clinical | 1 | 2012 | 1164 | 0.220 |
Why?
|
Anesthesia | 1 | 2014 | 1561 | 0.220 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 3068 | 0.220 |
Why?
|
Adult | 39 | 2022 | 214055 | 0.210 |
Why?
|
Time Factors | 10 | 2019 | 40075 | 0.200 |
Why?
|
Retrospective Studies | 12 | 2022 | 77449 | 0.200 |
Why?
|
Tooth Loss | 1 | 2023 | 197 | 0.200 |
Why?
|
Quality of Health Care | 1 | 2017 | 4371 | 0.200 |
Why?
|
Cecum | 1 | 2022 | 237 | 0.200 |
Why?
|
Ambulatory Care | 1 | 2012 | 2708 | 0.200 |
Why?
|
Information Literacy | 1 | 2020 | 10 | 0.190 |
Why?
|
Rectal Diseases | 1 | 2022 | 143 | 0.190 |
Why?
|
Bhutan | 3 | 2017 | 60 | 0.190 |
Why?
|
Aspirin | 3 | 2020 | 3282 | 0.190 |
Why?
|
Male | 29 | 2023 | 350118 | 0.180 |
Why?
|
Glutens | 2 | 2021 | 230 | 0.180 |
Why?
|
Patient Selection | 1 | 2012 | 4215 | 0.180 |
Why?
|
Diet Surveys | 3 | 2020 | 1173 | 0.180 |
Why?
|
Periodontal Diseases | 1 | 2023 | 449 | 0.180 |
Why?
|
Quality of Life | 1 | 2021 | 12804 | 0.180 |
Why?
|
Antibodies, Bacterial | 2 | 2017 | 1470 | 0.170 |
Why?
|
Primary Health Care | 2 | 2021 | 4558 | 0.170 |
Why?
|
Intestinal Mucosa | 3 | 2020 | 3036 | 0.170 |
Why?
|
Medicare | 1 | 2017 | 6566 | 0.170 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 238 | 0.170 |
Why?
|
Ascites | 1 | 2021 | 344 | 0.170 |
Why?
|
Estrogen Replacement Therapy | 2 | 2018 | 1203 | 0.170 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5853 | 0.170 |
Why?
|
Heart Failure | 1 | 2022 | 10900 | 0.160 |
Why?
|
Colitis, Lymphocytic | 1 | 2018 | 25 | 0.160 |
Why?
|
Colitis, Collagenous | 1 | 2018 | 26 | 0.160 |
Why?
|
Aged, 80 and over | 11 | 2020 | 57776 | 0.160 |
Why?
|
Dinoprostone | 1 | 2020 | 600 | 0.150 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2022 | 548 | 0.150 |
Why?
|
Dietary Fats | 2 | 2017 | 2017 | 0.150 |
Why?
|
Proportional Hazards Models | 13 | 2019 | 12354 | 0.150 |
Why?
|
Physicians, Primary Care | 1 | 2024 | 591 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2018 | 342 | 0.140 |
Why?
|
Suppositories | 1 | 2016 | 15 | 0.140 |
Why?
|
Fluorocarbons | 1 | 2021 | 452 | 0.140 |
Why?
|
End Stage Liver Disease | 1 | 2020 | 314 | 0.140 |
Why?
|
Melena | 1 | 2015 | 34 | 0.140 |
Why?
|
Seroepidemiologic Studies | 2 | 2017 | 401 | 0.140 |
Why?
|
United States | 16 | 2020 | 69872 | 0.140 |
Why?
|
Cost-Benefit Analysis | 2 | 2021 | 5391 | 0.140 |
Why?
|
Duodenum | 1 | 2019 | 483 | 0.130 |
Why?
|
Reproductive History | 2 | 2018 | 209 | 0.130 |
Why?
|
Enema | 1 | 2016 | 141 | 0.130 |
Why?
|
Follow-Up Studies | 15 | 2023 | 39050 | 0.130 |
Why?
|
Appointments and Schedules | 1 | 2019 | 417 | 0.130 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 253 | 0.130 |
Why?
|
Androgens | 1 | 2022 | 1281 | 0.130 |
Why?
|
Colon, Ascending | 1 | 2014 | 16 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 551 | 0.120 |
Why?
|
Smoking | 6 | 2022 | 8987 | 0.120 |
Why?
|
Capsule Endoscopy | 1 | 2015 | 125 | 0.120 |
Why?
|
Anesthesia Department, Hospital | 1 | 2014 | 68 | 0.120 |
Why?
|
Young Adult | 10 | 2020 | 56430 | 0.120 |
Why?
|
Topography, Medical | 1 | 2013 | 37 | 0.120 |
Why?
|
Nurses | 2 | 2021 | 2461 | 0.120 |
Why?
|
MutS Homolog 2 Protein | 1 | 2014 | 200 | 0.120 |
Why?
|
Multivariate Analysis | 6 | 2017 | 12245 | 0.110 |
Why?
|
Risk Assessment | 10 | 2020 | 23338 | 0.110 |
Why?
|
Postoperative Complications | 1 | 2016 | 15295 | 0.110 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2014 | 93 | 0.110 |
Why?
|
Dietary Fiber | 2 | 2015 | 760 | 0.110 |
Why?
|
Health Surveys | 7 | 2018 | 4037 | 0.110 |
Why?
|
Medical Records | 1 | 2018 | 1413 | 0.110 |
Why?
|
Alcohol Drinking | 2 | 2022 | 3966 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 3870 | 0.110 |
Why?
|
Databases, Factual | 2 | 2019 | 7729 | 0.110 |
Why?
|
Boston | 3 | 2017 | 9313 | 0.110 |
Why?
|
Patient Care Management | 1 | 2016 | 306 | 0.110 |
Why?
|
Crowding | 1 | 2013 | 145 | 0.110 |
Why?
|
Hemodynamics | 1 | 2022 | 4199 | 0.100 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 349 | 0.100 |
Why?
|
Viral Load | 2 | 2018 | 3299 | 0.100 |
Why?
|
Adolescent | 9 | 2020 | 85781 | 0.100 |
Why?
|
Zinc | 1 | 2015 | 684 | 0.100 |
Why?
|
Colitis | 1 | 2019 | 1170 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2012 | 0.100 |
Why?
|
DNA Mismatch Repair | 1 | 2014 | 426 | 0.090 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 509 | 0.090 |
Why?
|
Feeding Behavior | 2 | 2020 | 3188 | 0.090 |
Why?
|
Electronic Mail | 1 | 2012 | 213 | 0.090 |
Why?
|
Attitude to Computers | 1 | 2011 | 202 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2018 | 1838 | 0.090 |
Why?
|
Cohort Studies | 9 | 2022 | 40561 | 0.090 |
Why?
|
Chronic Disease | 4 | 2022 | 9146 | 0.090 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 890 | 0.090 |
Why?
|
Diet | 3 | 2021 | 7939 | 0.090 |
Why?
|
Adenosine Triphosphatases | 1 | 2014 | 839 | 0.090 |
Why?
|
Program Evaluation | 1 | 2018 | 2488 | 0.090 |
Why?
|
Fatty Acids | 1 | 2017 | 1809 | 0.090 |
Why?
|
Educational Status | 1 | 2017 | 2540 | 0.090 |
Why?
|
Testosterone | 2 | 2022 | 2420 | 0.090 |
Why?
|
Informed Consent | 1 | 2016 | 995 | 0.090 |
Why?
|
Rectum | 1 | 2014 | 904 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1060 | 0.080 |
Why?
|
Weight Gain | 1 | 2018 | 2292 | 0.080 |
Why?
|
Case-Control Studies | 7 | 2022 | 21746 | 0.080 |
Why?
|
Administration, Oral | 1 | 2016 | 3913 | 0.080 |
Why?
|
HIV-1 | 2 | 2018 | 6939 | 0.080 |
Why?
|
Sex Factors | 1 | 2021 | 10397 | 0.070 |
Why?
|
Logistic Models | 3 | 2017 | 13408 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1692 | 0.070 |
Why?
|
Bile Duct Diseases | 1 | 2007 | 100 | 0.070 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2007 | 101 | 0.070 |
Why?
|
Anemia | 1 | 2015 | 1506 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2015 | 1333 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2016 | 3200 | 0.070 |
Why?
|
Patient Admission | 1 | 2013 | 1380 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2017 | 4560 | 0.070 |
Why?
|
Community Health Centers | 1 | 2009 | 430 | 0.070 |
Why?
|
Bile Ducts | 1 | 2007 | 284 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15076 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6489 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2759 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2375 | 0.060 |
Why?
|
Pancreatic Ducts | 1 | 2007 | 328 | 0.060 |
Why?
|
Decision Making | 3 | 2024 | 3887 | 0.060 |
Why?
|
Pancreatic Diseases | 1 | 2007 | 350 | 0.060 |
Why?
|
Obesity | 2 | 2018 | 12745 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2938 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3778 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4567 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2043 | 0.060 |
Why?
|
HIV Infections | 3 | 2018 | 16718 | 0.060 |
Why?
|
Patient Participation | 2 | 2024 | 1457 | 0.060 |
Why?
|
Feces | 2 | 2020 | 1401 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2948 | 0.060 |
Why?
|
Lymphocyte Count | 2 | 2018 | 793 | 0.060 |
Why?
|
Motor Activity | 1 | 2013 | 2714 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3610 | 0.060 |
Why?
|
Inflammation | 2 | 2020 | 10638 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5867 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2012 | 5078 | 0.050 |
Why?
|
Genotype | 2 | 2014 | 12951 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2011 | 1343 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4554 | 0.050 |
Why?
|
Gastrointestinal Transit | 1 | 2022 | 96 | 0.050 |
Why?
|
Prognosis | 2 | 2019 | 29063 | 0.050 |
Why?
|
Self Report | 3 | 2020 | 3558 | 0.050 |
Why?
|
Anticoagulants | 1 | 2015 | 4599 | 0.050 |
Why?
|
Healthcare Disparities | 2 | 2013 | 3158 | 0.050 |
Why?
|
Body Mass Index | 5 | 2018 | 12720 | 0.040 |
Why?
|
DNA Methylation | 1 | 2014 | 4286 | 0.040 |
Why?
|
Manometry | 1 | 2022 | 445 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2214 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 734 | 0.040 |
Why?
|
Inflammation Mediators | 2 | 2018 | 1889 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2278 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2012 | 2988 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4479 | 0.040 |
Why?
|
Sleep | 1 | 2014 | 4623 | 0.040 |
Why?
|
Vitamin D | 1 | 2011 | 3223 | 0.040 |
Why?
|
Schools | 2 | 2017 | 1433 | 0.040 |
Why?
|
Clinical Competence | 1 | 2013 | 4687 | 0.040 |
Why?
|
Constipation | 1 | 2022 | 546 | 0.040 |
Why?
|
Efficiency | 1 | 2020 | 462 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7880 | 0.040 |
Why?
|
Metagenomics | 1 | 2020 | 428 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9648 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 25043 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 954 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5137 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 405 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4253 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 2020 | 0.030 |
Why?
|
Colectomy | 1 | 2020 | 683 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2020 | 12026 | 0.030 |
Why?
|
Internal Medicine | 1 | 2021 | 1009 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1147 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2008 | 3022 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2018 | 1880 | 0.030 |
Why?
|
Splenomegaly | 1 | 2014 | 190 | 0.030 |
Why?
|
Risk | 2 | 2018 | 9687 | 0.030 |
Why?
|
Smoking Cessation | 2 | 2018 | 2071 | 0.030 |
Why?
|
Cytokines | 2 | 2018 | 7322 | 0.030 |
Why?
|
Depression | 1 | 2012 | 7766 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 575 | 0.030 |
Why?
|
Seafood | 1 | 2015 | 384 | 0.030 |
Why?
|
Micromanipulation | 1 | 2012 | 53 | 0.030 |
Why?
|
Cytarabine | 1 | 2014 | 692 | 0.030 |
Why?
|
Pandemics | 2 | 2022 | 8388 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2018 | 1348 | 0.030 |
Why?
|
Marital Status | 1 | 2013 | 437 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2017 | 63114 | 0.020 |
Why?
|
Age Factors | 3 | 2013 | 18370 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1462 | 0.020 |
Why?
|
Virus Replication | 1 | 2018 | 2534 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2024 | 3229 | 0.020 |
Why?
|
New England | 1 | 2013 | 1022 | 0.020 |
Why?
|
Women | 1 | 2012 | 230 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2012 | 455 | 0.020 |
Why?
|
Menopause | 1 | 2018 | 1626 | 0.020 |
Why?
|
Diuretics | 1 | 2013 | 592 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2014 | 640 | 0.020 |
Why?
|
Fruit | 1 | 2015 | 1142 | 0.020 |
Why?
|
Vegetables | 1 | 2015 | 1182 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1477 | 0.020 |
Why?
|
Geography | 1 | 2012 | 669 | 0.020 |
Why?
|
Eosinophilia | 1 | 2014 | 541 | 0.020 |
Why?
|
Stomach | 1 | 2014 | 697 | 0.020 |
Why?
|
Women's Health | 1 | 2019 | 2034 | 0.020 |
Why?
|
Caregivers | 1 | 2020 | 2094 | 0.020 |
Why?
|
Disease Progression | 2 | 2017 | 13284 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3586 | 0.020 |
Why?
|
Students | 1 | 2017 | 1654 | 0.020 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2015 | 990 | 0.020 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2012 | 428 | 0.020 |
Why?
|
Diarrhea | 1 | 2014 | 1348 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2013 | 13989 | 0.020 |
Why?
|
Fatigue | 1 | 2014 | 1531 | 0.020 |
Why?
|
Eating | 1 | 2013 | 1536 | 0.020 |
Why?
|
Poverty Areas | 1 | 2008 | 275 | 0.020 |
Why?
|
HLA Antigens | 1 | 2012 | 1381 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4320 | 0.020 |
Why?
|
Nanotechnology | 1 | 2012 | 710 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3271 | 0.020 |
Why?
|
Epitopes | 1 | 2012 | 2571 | 0.020 |
Why?
|
Cultural Competency | 1 | 2008 | 289 | 0.020 |
Why?
|
Birth Weight | 1 | 2013 | 2069 | 0.020 |
Why?
|
Breast Feeding | 1 | 2013 | 1338 | 0.020 |
Why?
|
HIV | 1 | 2012 | 1604 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16365 | 0.010 |
Why?
|
Infant, Premature | 1 | 2013 | 2044 | 0.010 |
Why?
|
RNA, Viral | 1 | 2012 | 2902 | 0.010 |
Why?
|
Postmenopause | 1 | 2012 | 2461 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2012 | 3206 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9849 | 0.010 |
Why?
|
Infant | 1 | 2024 | 35136 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2012 | 2050 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6756 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15226 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5974 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2008 | 2539 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5987 | 0.010 |
Why?
|
Heart Diseases | 1 | 2014 | 2788 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 5985 | 0.010 |
Why?
|
Life Style | 1 | 2012 | 3835 | 0.010 |
Why?
|
Urban Population | 1 | 2008 | 2021 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12959 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15519 | 0.010 |
Why?
|
Health Behavior | 1 | 2009 | 2636 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5442 | 0.010 |
Why?
|
Image Enhancement | 1 | 2007 | 2921 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17446 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23403 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 41006 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2012 | 10180 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 3923 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 25625 | 0.010 |
Why?
|
Child | 1 | 2017 | 77709 | 0.010 |
Why?
|